je.st
news
Home
› Allied-Bristol Life Sciences Licenses Platform Technology And Lead Molecules From Yale University
Allied-Bristol Life Sciences Licenses Platform Technology And Lead Molecules From Yale University
2015-09-02 07:19:10| drugdiscoveryonline News Articles
Allied-Bristol Life Sciences, LLC, a biopharmaceutical enterprise jointly owned between Allied Minds and Bristol-Myers Squibb Company, announced that it has entered into a worldwide licensing agreement with Yale University for a proprietary platform technology and associated lead molecules that will be further developed to treat diseases such as prostate cancer, a leading cause of cancer-related deaths among American men
Tags: life
technology
university
lead
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||